Emergent boosts countermeasures repertoire with $325M deal for smallpox newcomer Tembexa fkansteiner Mon, 05/16/2022 – 13:54 More: Emergent boosts countermeasures repertoire with 5M deal for smallpox newcomer Tembexa Source: fierce
read moreGlaxoSmithKline is no more: Meet the scaled down ‘GSK’ badams Mon, 05/16/2022 – 12:58 More: GlaxoSmithKline is no more: Meet the scaled down 'GSK' Source: fierce
read moreRDT inks deals to push oral film tech to COVID-19 vaccine firms ntaylor Mon, 05/16/2022 – 11:20 More: RDT inks deals to push oral film tech to COVID-19 vaccine firms Source: fierce
read moreJ&J program adds Ena’s infectious disease nasal spray to roster ntaylor Mon, 05/16/2022 – 11:14 More: J&J program adds Ena's infectious disease nasal spray to roster Source: fierce
read moreModerna may claw back $700,000 salary from Gomez after his 1-day stay kdunleavy Mon, 05/16/2022 – 11:06 More: Moderna may claw back 0,000 salary from Gomez after his 1-day stay Source: fierce
read moreSarclisa is a monoclonal antibody which targets a specific epitope on the CD38 receptor on multiple myeloma cells More: Sanofi’s Sarclisa combination shows positive results in multiple myeloma patients Source: News
read more© 1994 - 2022 B.M. Pharmaceuticals